Citations refer to the original publication, not to a Scieee localized version.
Abad, M. R., Alerany, C., Gonzalez, L. I., Neth, O., Payares-Herrera, C., Rodríguez-Gallego, C., Trillo, J. L., Herrmann, K. H., Figueiredo, R., & Gil, A. (2025). Value contribution of leniolisib in the Treatment of Activated PI3Kδ syndrome (APDS) in Spain using Multi-Criteria Decision Analysis (MCDA). Global and Regional Health Technology Assessment, 12(1), 9–15. https://doi.org/10.33393/grhta.2025.3199
Abad, María Reyes, et al. “Value contribution of leniolisib in the Treatment of Activated PI3Kδ syndrome (APDS) in Spain using Multi-Criteria Decision Analysis (MCDA).” Global and Regional Health Technology Assessment, vol. 12, no. 1, 2025, pp. 9–15. https://doi.org/10.33393/grhta.2025.3199.
Abad, María Reyes, Carmen Alerany, Luis Ignacio Gonzalez, Olaf Neth, Concepción Payares-Herrera, Carlos Rodríguez-Gallego, Jose Luis Trillo, Kirsten H. Herrmann, Raquel Figueiredo, and Alicia Gil. “Value contribution of leniolisib in the Treatment of Activated PI3Kδ syndrome (APDS) in Spain using Multi-Criteria Decision Analysis (MCDA).” Global and Regional Health Technology Assessment 12, no. 1 (2025): 9–15. https://doi.org/10.33393/grhta.2025.3199.
Abad, M. R. et al. (2025) ‘Value contribution of leniolisib in the Treatment of Activated PI3Kδ syndrome (APDS) in Spain using Multi-Criteria Decision Analysis (MCDA)’, Global and Regional Health Technology Assessment, 12(1), pp. 9–15. Available at: https://doi.org/10.33393/grhta.2025.3199.
M. R. Abad et al., “Value contribution of leniolisib in the Treatment of Activated PI3Kδ syndrome (APDS) in Spain using Multi-Criteria Decision Analysis (MCDA),” Global and Regional Health Technology Assessment, vol. 12, no. 1, pp. 9–15, 2025, doi: 10.33393/grhta.2025.3199.
@article{abad2025value,
author = {Abad, María Reyes and Alerany, Carmen and Gonzalez, Luis Ignacio and Neth, Olaf and Payares-Herrera, Concepción and Rodríguez-Gallego, Carlos and Trillo, Jose Luis and Herrmann, Kirsten H. and Figueiredo, Raquel and Gil, Alicia},
title = {Value contribution of leniolisib in the Treatment of Activated PI3Kδ syndrome (APDS) in Spain using Multi-Criteria Decision Analysis (MCDA)},
journal = {Global and Regional Health Technology Assessment},
year = {2025},
volume = {12},
number = {1},
pages = {9--15},
doi = {10.33393/grhta.2025.3199},
url = {https://doi.org/10.33393/grhta.2025.3199}
}
